Examples of using Is presented in table in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
A summary of results is presented in Table 3.
The implementation of payments to the former ISPA projects adopted before accession is presented in Table 3.
A single irritation category(Category 2) is presented in Table 3.2.2, using the results of animal testing.
Investigator analysis on data at the end of enrolment is presented in Table 1.
Phase III clinical studies, C209 and C215, for patients receiving the emtricitabine/tenofovir disoproxil fumarate background regimen) is presented in Table 5.
The Commission's interpretation is presented in Table 1.
the primary efficacy outcome is presented in Table 3.
A summary of pharmacokinetic data is presented in Table 1.
maximum dose received during the OL LI phase is presented in Table 7.
An analysis of non-CABG-related bleeding is presented in Table 2.
The MMR rate at 12, 24, 36, 48, 60 and 72 months is presented in Table 5.
baseline CD4 count(pooled DUET data) is presented in table 4.
The response to treatment in both of these trials is presented in Table 9.
The overall volume of national State aid granted in the EU to the sectors covered by this Survey is presented in Table 1.
The response to treatment in both of these trials is presented in Table 4.
Vaccine efficacy against high grade cervical lesions associated with HPV-16/18 observed in TVC at end of study is presented in Table 3.
Vaccine efficacy against the primary endpoint CIN2+ is presented in Table 1.
that is specifically aimed at the outermost regions of the Union is presented in Table 17 below.
A tabular summary of the secondary efficacy results is presented in Table 3.
The frequency of grade 3 and 4 haematological abnormalities is presented in Table 4.
The share of energy from renewable sources in heating and cooling is presented in Table 4.
Vaccine efficacy against the primary endpoint CIN2+ at the end of study is presented in Table 1.
The detailed breakdown of estimated staff numbers by various categories is presented in Table 3.
The corresponding estimated increase in the multi-annual European expenditure is presented in Table 4.
A summary of action as a function of the test results during treatment with Zinbryta is presented in table 1 below.
The investigator radiographic review of rPFS performed as a follow up sensitivity analysis is presented in Table 3 and Figure 2.